SCHEMBL1507366

SCHEMBL1507366

OCC[C@@]1(Cc2ccccc2)CNC[C@H]1c1ccc(Cl)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.37
SLC6A4 P31645 10/20 0.37
SLC6A3 Q01959 5/20 0.34
CYP2D6 P10635 1/20 0.33
KCNH2 Q12809 1/20 0.33
TRPM5 Q9NZQ8 1/20 0.33
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
KDM1A O60341 2/20 0.32
RCOR1 Q9UKL0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3643149 0.91 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1439365 0.90 HTT (0.37) SLC6A2SLC6A4SLC6A3CYP2D6KDM1A
SCHEMBL3650756 0.84 KDM1A (0.47) SLC6A2SLC6A4SLC6A3CYP2D6KDM1A
SCHEMBL1439673 0.84 KDM1A (0.47) SLC6A2SLC6A4SLC6A3KDM1ARCOR1
SCHEMBL1507478 0.84 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2784188 0.81 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL1507378 0.80 SLC6A4 (0.33) SLC6A2SLC6A4SLC6A3KDM1ARCOR1
SCHEMBL3710431 0.79 MEN1 (0.36) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL2228579 0.76 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL2228553 0.76 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2294063-A1 PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-03-16 EP disclosed
EP-2185540-A1 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-05-19 EP disclosed
WO-2009150110-A1 PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-12-17 WO disclosed
WO-2009019163-A1 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-12 WO disclosed